Top View
- (12) United States Patent (10) Patent No.: US 8,735,376 B2 Muhammad Et Al
- Oral Naftopidil Suppresses Human Renal-Cell Carcinoma by Inducing G 1 Cell-Cycle Arrest in Tumor and Vascular Endothelial Cells
- Adrenoceptor Pharmacology
- (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
- WO 2016/199161 A2 15 December 2016 (15.12.2016) P O P C T
- New Medical Treatments for Lower Urinary Tract Symptoms Due To
- Npgrj NCHEMBIO 806 415..416
- Doxazosin, an 1-Adrenoceptor Antagonist, Inhibits Serotonin-Induced Shape Change in Human Platelets
- Download Product Insert (PDF)
- A Full Cycle Anti-Viral Drug Screen Identifies a Clinical Compound
- Ramelteon Combined with an Α1-Blocker Decreases Nocturia In
- Wo 2007/044693 A2
- (12) Patent Application Publication (10) Pub. No.: US 2014/0038949 A1 Schultz Et Al
- Drug Repurposing to Treat Glucocorticoid Resistance in Asthma Alberta L
- Naftopidil Improves Locomotor Activity and Urinary Frequency in Rats with Pelvic Venous Congestion
- A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
- Neurobiology of Cancer: Introduction of New Drugs in the Treatment and Prevention of Cancer
- Influence of the [Alpha] 1-Adrenoceptor Antagonists
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Silodosin Is Effective for Treatment of LUTS in Men with BPH: a Systematic Review
- Piperazine-Based Alpha-1 AR Blocker, Naftopidil, Selectively Suppresses Malignant Human Bladder Cells Via Induction of Apoptosis
- Using Slice Patch-Clamp Technique for Inhibitory Postsynaptic Current in Substantia Gelatinosa Neurons from Lumbosacral Spinal Cord in Rats
- Drug Repositioning of the Α1-Adrenergic Receptor Antagonist Naftopidil: a Potential New Anti-Cancer Drug?
- Add-On Therapy with the Α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats
- Evidence for the Effectiveness of Anti-Hypertensive Medicines In- Literature Quality Assessment Cluded on the NRDL
- Targeting Quorum Sensing
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Supplementary Material
- Comparative Evaluation of Naftopidil and Tamsulosin in the Treatment of Patients with Lower Urinary Tract Symptoms with Benign Prostatic Hyperplasia
- Naftopidil for the Treatment of Urinary Symptoms in Patients with Benign Prostatic Hyperplasia
- A Randomized Study Comparing Once-Daily and Thrice-Daily Naftopidil 75 Mg/Day for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia
- A Prospective Randomized Controlled Study on the Suppression of Prostate Cancer by Naftopidil (SNAP)
- Known Bioactive Library: LOPAC 1
- Lack of Influence of Substrate on Ligand Interaction with the Human Multidrug and Toxin Extruder, MATE1 S
- Analyses of the Mode of Action of an Alpha-Adrenoceptor Blocker in Substantia Gelatinosa Neurons in Rats
- Naftopidil, a Selective A1-Adrenoceptor Antagonist, Suppresses Human Prostate Tumor Growth by Altering Interactions Between Tumor Cells and Stroma